Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease

July 22, 2022 updated by: Ebru Akbuğa Koç, Yeditepe University

Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic

Our aim has been determined to investigate the effect of physical exercise alone and in combination with cognitive exercise, on cognitive, physical function and quality of life in individuals with Alzheimer's Disease during the Covid-19 pandemic period.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Eyalet/Yerleşke
      • İstanbul, Eyalet/Yerleşke, Turkey, 34865
        • Yeditepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥ 65 years and older
  • Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist,
  • MOCA ≥ 13
  • Clinical Dementia Rating Scale < 2
  • Having sufficient wireless support or telephone connection where the person lives
  • Who gave consent to participate in the study
  • No history of any neurological or orthopedic injury that could prevent participation in the study and affect functional mobility.

Exclusion Criteria:

  • Geriatric Depression Scale score > 11
  • Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.)
  • Clinically significant aphasia (must be able to understand the therapist's commands)
  • Significant visual or sensory impairment
  • MoCA < 13
  • Having a severe musculoskeletal disorder
  • Having paralysis
  • Impaired balance
  • The presence of severe lung and heart disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical exercise and computerized cognitive stimulation

Supervised Physical Exercise Program (SPEP) sessions will be performed simultaneously online together with the physiotherapist and the patient. Participants will be able to do the exercises together with their caregivers if needed.

The Computerized Cognitive Stimulation Program (CCSP) (Beynex) will be planned for 12 weeks, 5 days a week, approximately 10 minutes, for a total of 40 sessions.

Fisrtly, the use of CCSP will be demonstrated to the patients. Then, it will be given as home program. While the patients play the games in CCSP via their smartphones, their caregivers will be informed in detail about accompanying the patients if they need it. The follow-up of cognitive stimulation will be made with the person accompanying the patient over the phone.

Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

SPEP are planned for 12 weeks, 2 times a week, once a day, 60 minutes / 1 hour. The CCSP is planned for 12 weeks, minimum 3 to maximum 5 days a week, approximately 10 minutes, for a total of 36-60 sessions
Experimental: physical exercise

SPEP sessions will be demonstrated to individuals by a 6-year-experienced physiotherapist via videoconference (Zoom Inc.) and the exercises will be performed simultaneously online together with the physiotherapist and the patient. Participants will be able to do the exercises together with their caregivers if needed.

Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

SPEP are planned for 12 weeks, 2 times a week, once a day, 60 minutes / 1 hour
No Intervention: control

The individuals included in this group will be informed that they should continue their normal daily life activities.

Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alzheimer's Disease Related Quality of Life Scale
Time Frame: 24 weeks
This scale evaluates health-related quality of life in individuals with AD. The scale includes 40 questions in total and examines 5 quality of life domains (A-Social Interaction, B-Self Awareness, C-Affect and Mood, D- Enjoying Activities, E-Interaction with the Environment).
24 weeks
Montreal Cognitive Assessment Scale
Time Frame: 24 weeks
MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment.
24 weeks
Berg Balance Scale
Time Frame: 24 weeks
Berg Balance Scale measures static and dynamic balance in elderly individuals.
24 weeks
Time up and Go Test
Time Frame: 24 weeks
TUG test evaluates fall risk, mobility and physical performance in the elderly
24 weeks
Sit to Stand Test
Time Frame: 24 weeks
Sit-to-stand test will be performed on an armless chair with a height of 46 cm to determine the physical fitness level of elderly individuals
24 weeks
Arm Curl Test
Time Frame: 24 weeks
The Arm Curl test is one of the subtests of the Senior fitness test and it is performed to evaluate upper extremity muscle strength
24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Katz Activities of Daily Living Scale
Time Frame: 24 weeks
Katz ADLs consist of six questions that include information about bathing, dressing, toilet, movement, excretion, and feeding activities.
24 weeks
Lawton Instrumental Activities of Daily Living Scale
Time Frame: 24 weeks
Lawton IADL scale consists of 8 items and a single subscale. In addition, it consists of eight questions about using the phone, preparing meals, shopping, doing daily household chores, washing clothes, getting on the transportation vehicle, taking medicines and money management
24 weeks
Geriatric Depression Scale (Short Form)
Time Frame: 24 weeks
The GDS Short Form (GDS-15) is a 15-item scale that is used for the diagnosis of depression in elderly individuals
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2021

Primary Completion (Actual)

July 23, 2021

Study Completion (Actual)

December 25, 2021

Study Registration Dates

First Submitted

April 10, 2021

First Submitted That Met QC Criteria

April 10, 2021

First Posted (Actual)

April 13, 2021

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on Physical exercise and computerized cognitive training

Subscribe